OnabotulinumtoxinA for the treatment of neurogenic detrusor overactivity in children.
Paul F AustinIsrael FrancoEric DobremezPawel KrollWilson TitanjiTill GeibBrenda JenkinsPiet B HoebekePublished in: Neurourology and urodynamics (2020)
OnabotulinumtoxinA was well tolerated and effective for the treatment of NDO in children; 200 U showed greater efficacy in reducing bladder pressure and increasing bladder capacity.